Please assess the completion status of the following clinical trial:

Trial Title: BIO|MASTER.Ilivia Family / Plexa

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Standard indication for ICD or CRT-D therapy according to clinical practice~* De novo implantation or upgrade/exchange (group A only) from existing ICD, CRT-D or pacemaker implant~* Patient is able to understand the nature of the clinical investigation and provides written informed consent~* Patient is able and willing to complete all routine study visits at the investigational site~* Patient accepts Home Monitoring concept~* Age ≥ 18 years~Exclusion Criteria:~* Contraindication to ICD or CRT-D therapy, respectively~* For CRT-D patients in group A only: physician not willing to activate MultiPole Pacing in the patient~* Cardiac surgical procedure planned within 6 months after implantation (including also interventional procedures like ablation, valve replacement etc.). Procedures to occur during or prior to implantation are not exclusionary.~* Expected to receive heart transplant or ventricular assist device within 6 months~* Life expectancy less than 6 months~* Participation in any other interventional clinical investigation~* Pregnant or breastfeeding at time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ilivia ICD Family (Type: OTHER): Implant of the new Ilivia ICD Family. Device measurements, pre-defined programming and Adverse Event Reporting
- Plexa ICD lead (Type: OTHER): Implant of the new Plexa ICD lead. Device measurements and Adverse Event Reporting
- Ilivia ICD and Plexa lead (Type: OTHER): Implant of the new Ilivia ICD Family and the new Plexa lead. Device measurements, pre-defined programming and Adverse Event Reporting

Based on this trial design, predict the completion outcome and termination type (if applicable).